1 Introduction Over one million cardiac pacemakers are implanted every year worldwide,[11 of which approximately 200,000 are implanted in the United States alone.121 Combined with an aging population and increasing p...1 Introduction Over one million cardiac pacemakers are implanted every year worldwide,[11 of which approximately 200,000 are implanted in the United States alone.121 Combined with an aging population and increasing pacing indications, these numbers are expected to grow. Since the first pacemaker implantation in 1950s, cardiac pacemaker technology has rapidly advanced. Reduction in generator size, increased battery longevity, quality of pacemaker leads, algorithmic and rate responsive programming-all have revolutionized and transformed the implantation and management of transvenous cardiac pacemaker （TV-PPM）.展开更多
As the population continues to age, aortic stenosis re- mains as the most prevalent valvular disease in Western countries. The number of elderly patients with aortic ste- nosis continues to pose both a diagnostic and ...As the population continues to age, aortic stenosis re- mains as the most prevalent valvular disease in Western countries. The number of elderly patients with aortic ste- nosis continues to pose both a diagnostic and therapeutic challenge. Despite new advances such as transcatheter aortic valvular replacement （TAVR）, there is still much pa- tient-provider decision making that needs to take place giv- en the comorbidities and complex goals of care in an elderly patient population.展开更多
文摘1 Introduction Over one million cardiac pacemakers are implanted every year worldwide,[11 of which approximately 200,000 are implanted in the United States alone.121 Combined with an aging population and increasing pacing indications, these numbers are expected to grow. Since the first pacemaker implantation in 1950s, cardiac pacemaker technology has rapidly advanced. Reduction in generator size, increased battery longevity, quality of pacemaker leads, algorithmic and rate responsive programming-all have revolutionized and transformed the implantation and management of transvenous cardiac pacemaker （TV-PPM）.
文摘As the population continues to age, aortic stenosis re- mains as the most prevalent valvular disease in Western countries. The number of elderly patients with aortic ste- nosis continues to pose both a diagnostic and therapeutic challenge. Despite new advances such as transcatheter aortic valvular replacement （TAVR）, there is still much pa- tient-provider decision making that needs to take place giv- en the comorbidities and complex goals of care in an elderly patient population.
